- Home
- TRT vs LGVN Comparison
TRT vs LGVN Comparison
Compare TRT & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRT
- LGVN
- Stock Information
- Founded
- TRT 1958
- LGVN 2014
- Country
- TRT United States
- LGVN United States
- Employees
- TRT N/A
- LGVN N/A
- Industry
- TRT Industrial Machinery/Components
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- TRT Technology
- LGVN Health Care
- Exchange
- TRT Nasdaq
- LGVN Nasdaq
- Market Cap
- TRT 21.6M
- LGVN 23.4M
- IPO Year
- TRT N/A
- LGVN 2021
- Fundamental
- Price
- TRT $5.39
- LGVN $1.31
- Analyst Decision
- TRT
- LGVN Strong Buy
- Analyst Count
- TRT 0
- LGVN 3
- Target Price
- TRT N/A
- LGVN $8.67
- AVG Volume (30 Days)
- TRT 29.0K
- LGVN 147.7K
- Earning Date
- TRT 05-13-2025
- LGVN 08-13-2025
- Dividend Yield
- TRT N/A
- LGVN N/A
- EPS Growth
- TRT N/A
- LGVN N/A
- EPS
- TRT 0.00
- LGVN N/A
- Revenue
- TRT $35,548,000.00
- LGVN $2,225,000.00
- Revenue This Year
- TRT N/A
- LGVN N/A
- Revenue Next Year
- TRT N/A
- LGVN $51.48
- P/E Ratio
- TRT $1,246.17
- LGVN N/A
- Revenue Growth
- TRT N/A
- LGVN 127.50
- 52 Week Low
- TRT $4.62
- LGVN $1.14
- 52 Week High
- TRT $7.88
- LGVN $6.40
- Technical
- Relative Strength Index (RSI)
- TRT 55.69
- LGVN 50.13
- Support Level
- TRT $4.89
- LGVN $1.15
- Resistance Level
- TRT $6.10
- LGVN $1.32
- Average True Range (ATR)
- TRT 0.39
- LGVN 0.09
- MACD
- TRT 0.03
- LGVN 0.01
- Stochastic Oscillator
- TRT 43.26
- LGVN 45.31
About TRT Trio-Tech International
Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.